The impact of socio-economic factors, mental health and functional status on survival in a sample of AIDS patients

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 9, Issue 6, 1997, Pages 671-680

  Palombi, L ^a   Mancinelli, S ^a   Liotta, G ^a   Narciso, P ^b   Marazzi, M C ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c LUMSA UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; DAILY LIFE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; INTERVIEW; ITALY; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SOCIOECONOMICS; SURVIVAL; HEALTH STATUS; PATHOPHYSIOLOGY; PSYCHOLOGY; SURVIVOR;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; FEMALE; HEALTH STATUS; HUMANS; MALE; MENTAL HEALTH; SOCIOECONOMIC FACTORS; SURVIVORS;

EID: 0030780272     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/713613229     Document Type: Article

References (37)

1. ABENI, D.D. & PERUCCI, C.A. (1993). Sopravvivenza dalla diagnosi di AIDS, Roma e Lazio 1982-92. GIAIDS, 4, 17-25.
2. - limphocyte count <50/μl. Journal of Infectious Diseases, 171, 829-836.
3. BUIRA, E., GATELL, J.M., BATALLA, J. et al. (1992). Influence of treatment with Zidovudine (ZDV) on the long-term survival of AIDS patients. Journal of Acquired Immune Deficiency Syndromes, 5, 737-742.
4. CAIRL, R.E., PFEIFFER, E., KELLER, D.M., BURKE, H. & SAMIS, H.V. (1983). Evaluation of the reliability and validity of the Functional Assessment Inventory. Journal of the American Geriatric Society, 33, 681-686.
5. CAUMARTIN, S., JOSEPH, G.J. & CHMIEL, J. (1992). Premorbid psychosocial factors associated with differential survival time in AIDS patients, VIIth International Conference on AIDS, Florence, June [abstract no. MC3105].
6. CENTER FOR DISEASE CONTROL (1987). Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR, 4, 1059-1071.
7. COOMBS, R.W. (1994). HIV-1 burden as a marker of disease progression and clinical response to therapy in AIDS. Clinical and Laboratory Medicine, 14(2), 301-311.
8. CRYSTAL, S. & JACKSON, M.M. (1989). Psychosocial adaptation and economic circumstances of persons with AIDS and ARC. Family and Community Health, 77-88.
9. D'ARMINIO MONFORTE, A., MAININI, F., BINI, T. et al. (1992). Survival differences for 547 AIDS cases in Milan. Journal of Acquired Immune Deficiency Syndromes, 5, 1276-1277.
10. DR GRUTTOLA, V., WULFHSON, M., FISCHL, M.A. et al. (1993). Modeling the relationship between survival and CD4 limphocytes in patients with AIDS and AIDS-related complex. Journal of Acquired Immune Deficiency Syndromes, 6, 359-365.
11. DUKE UNIVERSITY, CENTER FOR THE STUDY OF AGING AND HUMAN DEVELOPMENT (1978). Duke OARS, Multidimensional Functional Assessment: the OARS Methodology (2nd ed.). Durham, South Carolina.
12. EASTERBROOK, P.J., EMAMI, J. & GAZZARD, B. (1993a). Rate of CD4 cell decline and prediction of survival in zidovudine-treated patients. AIDS, 7, 959-967.
13. EASTERBROOK, P.J., EMAMI, J., MOYLE, G. et al. (1993b). Progressive CD4 cell depletion and death in zidovudine-treated patients. Journal of Acquired Immune Deficiency Syndromes, 6, 927-929.
14. FISCHL, M.A., RICHMAN, D.D., GRIECO, M.H. et al. (1987). The efficacy of Azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. New England Journal of Medicine, 317, 185-191.
15. GATZ, M., PEDERSEN, N.L. & HARRIS, J. (1987) Measurement characteristics of the mental health scale from the OARS. Journal of Gerontology, 42(3), 332-335.
16. GREEN, G. (1993). Editorial review: social support and HIV. AIDS Care, 1, 87-104.
17. HOGG, R.S., STRATHDEE, S.A., CRAIB, C.J.P., O'SHAUGHNESSY, M.V., MONTANER, J.S.G. & SCHECHTER, M.T. (1994). Lower socioeconomic status and shorter survival following HIV infection. Lancet, 344, 1120-1124.
18. HWA-GAN, C.H., DALE, M.L., CANDACE, N. et al. (1993). Survival and mortality patterns of an Acquired Immunodeficiency Syndrome (AIDS) cohort in a New York state. American Journal of Epidemiology, 138, 341-349.
19. ISRAËL, L., KOZAREVIC, D. & SARTORIUS, N. (1984). Source book of geriatric assessment, Vol. 1 (pp. 195-197). Basel: S. Karger AG.
20. JUSTICE, A.C., AIKEN, L.H., LAKE, E.T. et al. (1993). Functional survival staging for hospitalized AIDS patients. IXth International Conference on AIDS, Berlin, June [abstract no. B03-0963].
21. KATZ, S., DOWNS, T.D. & CASH, H.R. (1970). Progress in development of the index of ADL. The Gerontologist, 20-30.
22. KOOT, M., SCHUITEMAKER, H. & GOUDSMIT, J. (1994). The natural history of HIV-1: virus load and virus phenotype independent determinants of clinical course? Virology, 204, 223-233.
23. LAWTON, M.P. & BRODY, E. (1969). Assessment of older people: self-maintaining and instrumental activities of daily living. The Gerontologist, 9, 179-186.
24. LEMP, G.F., PAYNE, S.F., NEAL, D. et al. (1990). Survival trends for patients with AIDS. JAMA, 3, 402-406.
25. MARAZZI, M.C., MANCINELLI, S., PALOMBI, L., LIOTTA, G., SCARCELLA, P. & PANA, A. (1991). L'assistenza residenziale extraospedaliera per le persone con AIDS in Italia: stato attuale e possibili sviluppi. GIAIDS, 2, 227-231.
26. MARAZZI, M.C., PALOMBI, L., MANCINELLI, S., LIOTTA, G. & PANA, A. (1994). Care requirements of people with ARC/AIDS in Rome: non-hospital services. AIDS Care, 6, 95-104.
27. MARAZZI, M.C., PALOMBI, L., MANCINELLI, S., RICCARDI, F. & LIOTTA, G. (1990). II questionario di Valutazione Funzionale Multidimensionale per gli Infetti da HIV. Igiene e Sanita' Pubblica, 46(4-5), 338-348.
28. McCORMICK, W.C., HOPKINS, S.G., WOOD, R.W. et al. (1992). The Seattle appropriate level of care survey: health status and health services use in ambulatory persons with AIDS. AIDS Care, 3, 369-378.
29. MOLINA, J.M., FERCHAL, F., CHEVRET, S., BARATEAU, V., POIROT, C., MORINET, F. & MODAI, J. (1994). Quantification of HIV-1 virus load under zidovudine therapy in patients with symptomatic HIV infection: relation to disease progression. AIDS, 8(1), 27-33.
30. NIGHTINGALE, S.D., JOCKUSCH, J.D., HASLUND, I. et al. (1993). Logarithmic relationship of the CD4 count to survival in patients with human immunodeficiency virus infection. Archives of Internal Medicine, 153(11), 1313-1318.
31. PFEIFFER, E. (1979). A short psychiatric evaluation schedule: a new 15-item monotonic scale indicative of functional psychiatric disorder. In: Brain function in old age (pp. 228-236): Bayer Symposium VII. Springer Verlag.
32. REILLO, M. (1990). Psychosocial factors associated with prognosis in AIDS. Vth International Conference on AIDS, San Francisco [abstract no. SB372].
33. SELWYN, P.A., ALCABES, P., HARTEL, D. et al. (1992). Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. New England Journal of Medicine, 327, 1697-1703.
34. STOWE, A., ROSS, M.W., WODAK, A. et al. (1993). Significant relationships of injecting drug users and their implications for HIV/AIDS services. AIDS Care, 5, 23-33.
35. TURNER, B.J., MARKSON, L.E., McKEE, L. et al. (1991). The AIDS-defining diagnosis and subsequent complications: a survival-based severity index. Journal of Acquired Immune Deficiency Syndromes, 4, 1015-1024.
36. TURNER, B.J., MARKSON, L.E., McKEE, L.J., HOUCHENS, R. & FANNING, T. Health care delivery, zidovudine use and survival of women and men with AIDS. Journal of Acquired Immune Deficiency Syndromes, 7, 1250-1262.
37. VOLBERDING, P.A., LAGAKOS, S.W., KOCH, M.A. et al. (1990). Zidovudine in asymptomatic human immunodeficiency virus infection. New England Journal of Medicine, 322, 941-948.